Search Results for "Departments At At Biocryst Pharmaceuticals"
Original Source: BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases. BioCryst has progressed two novel compounds that are in late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma (CTCL). Additionally, BioCryst has a third product...
Matching Channels
None
Matching News
BioCryst, Presidio Call Off Proposed Acquisition
NEW YORK (AP) — BioCryst Pharmaceuticals Inc. and Presidio Pharmaceuticals Inc. said Friday that they have mutually agreed to end their agreement for Presidio to be purchased by BioCryst
PropThink: PropThink: BioCryst, Presidio Merger Creates Yet Another Competitor in the HCV Segment
By Jake King In an all-stock merger announced (http://investor.shareholder.com/biocryst/ReleaseDetail.cfm?ReleaseID=714478) Thursday morning, BioCryst Pharmaceuticals (NASDAQ:BCRX) will acquire pr...
FDA has safety concerns over BioCryst's hep C drug
RESEARCH TRIANGLE PARK, N.C. (AP) — Shares of drugmaker BioCryst Pharmaceuticals Inc. plunged Wednesday after the company said it was withdrawing its regulatory application for a hepatitis C drug du...
BioCryst withdraws BCX5191 lND following discussion with FDA
US biotech firm BioCryst Pharmaceuticals (Nasdaq: BCRX) says it is withdrawing its Investigational New Drug (IND) application for the antiviral nucleoside, BCX5191, following a discussion with the US...
BioCryst and Presidio to merge, creating new competitor in HCV arena
USA drugmaker BioCryst Pharmaceuticals (Nasdaq: BCRX) has signed a definitive accord to acquire privately held Presidio Pharmaceuticals in an all-stock transaction that values the latter at around $10...
BioCryst Investors Breathe Sight Of Relief, But What's Next?
By EP Vantage:Completing BioCryst's (BCRX) all-share takeover of Presidio Pharmaceuticals was always going to be tricky after the acquiring company's stock lost two-thirds of its value. But the curio...
Biocryst Pharmaceuticals: Company profile
Summary Website: Biocryst Pharmaceuticals Headquarters: North Carolina, USA SEC URL: Biocryst Pharmaceuticals Top BigBiotech ranking*: 45 *Ranking based on reported global biotech sales for year end...
BioCryst Won't Profit From Bird Flu Outbreak in China
DURHAM, NC (TheStreet) -- BioCryst Pharmaceuticals shares are trading higher because another bird flu outbreak has hit China, leading the China State Food and Drug Administration to approve the compa...
Matching PubMed Articles
Please cite this paper as: Hernandez et al. (2011) Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment. Influenza and Other R...
Childhood Onset Narcolepsy Cataplexy-More Than Just a Sleep Disorder.
Patients admitted to Cardiology and Cardiac Surgery Departments have an increased risk of ischemic stroke (IS). We analyzed clinical characteristics, quality of neurological care and mortality of in-h...
Case 22-2010 -- an 87-year-old woman with dementia and a seizure.
Objective: To determine the current pattern of use and handling of tungsten carbide debonding burs (TCDBs) within UK hospital-based orthodontic departments. Design: Cross-sectional survey. Subjects an...
